Skip to main content
Top
Published in: Quality of Life Research 9/2011

Open Access 01-11-2011

Maternal health-related quality of life after induction of labor or expectant monitoring in pregnancy complicated by intrauterine growth retardation beyond 36 weeks

Authors: Denise Bijlenga, Kim E. Boers, Erwin Birnie, Ben-Willem J. Mol, Sylvia C. M. Vijgen, Joris A. M. Van der Post, Christianne J. De Groot, Robbert J. P. Rijnders, Paula J. Pernet, Frans J. Roumen, Rob H. Stigter, Friso M. C. Delemarre, Henk A. Bremer, Martina Porath, Sicco A. Scherjon, Gouke J. Bonsel

Published in: Quality of Life Research | Issue 9/2011

Login to get access

Abstract

Objective

Pregnancies complicated by intrauterine growth retardation (IUGR) beyond 36 weeks of gestation are at increased risk of neonatal morbidity and mortality. Optimal treatment in IUGR at term is highly debated. Results from the multicenter DIGITAT (Disproportionate Intrauterine Growth Intervention Trial At Term) trial show that induction of labor and expectant monitoring result in equal neonatal and maternal outcomes for comparable cesarean section rates. We report the maternal health-related quality of life (HR-QoL) that was measured alongside the trial at several points in time.

Methods

Both randomized and non-randomized women were asked to participate in the HR-QoL study. Women were asked to fill out written validated questionnaires, covering background characteristics, condition-specific issues and the Short Form (SF-36), European Quality of Life (EuroQoL 6D3L), Hospital Anxiety and Depression scale (HADS), and Symptom Check List (SCL-90) at baseline, 6 weeks postpartum and 6 months postpartum. We compared the difference scores of all summary measures between the two management strategies by ANOVA. A repeated measures multivariate mixed model was defined to assess the effect of the management strategies on the physical (PCS) and mental (MCS) components of the SF-36. Analysis was by intention to treat.

Results

We analyzed data of 361 randomized and 198 non-randomized patients. There were no clinically relevant differences between the treatments at 6 weeks or 6 months postpartum on any summary measures; e.g., on the SF-36 (PCS: P = .09; MCS: P = .48). The PCS and the MCS were below norm values at inclusion. The PCS improved over time but stayed below norm values at 6 months, while the MCS did not improve.

Conclusion

In pregnancies complicated by IUGR beyond 36 weeks, induction of labor does not affect the long-term maternal quality of life.
Appendix
Available only for authorised users
Literature
1.
go back to reference Balcazar, H., Keefer, L., & Chard, T. (1994). Use of anthropometric indicators and maternal risk factors to evaluate intrauterine growth retardation in infants weighing more than 2500 grams at birth. Early Human Development, 36(3), 147–155.PubMedCrossRef Balcazar, H., Keefer, L., & Chard, T. (1994). Use of anthropometric indicators and maternal risk factors to evaluate intrauterine growth retardation in infants weighing more than 2500 grams at birth. Early Human Development, 36(3), 147–155.PubMedCrossRef
2.
go back to reference Chang, T. C., Robson, S. C., Spencer, J. A., & Gallivan, S. (1994). Prediction of perinatal morbidity at term in small fetuses: Comparison of fetal growth and Doppler ultrasound. British Journal of Obstetrics and Gynaecology, 101(5), 422–427.PubMedCrossRef Chang, T. C., Robson, S. C., Spencer, J. A., & Gallivan, S. (1994). Prediction of perinatal morbidity at term in small fetuses: Comparison of fetal growth and Doppler ultrasound. British Journal of Obstetrics and Gynaecology, 101(5), 422–427.PubMedCrossRef
3.
go back to reference Ohel, G., & Ruach, M. (1996). Perinatal outcome of idiopathic small for gestational age pregnancies at term: The effect of antenatal diagnosis. International Journal of Gynecology & Obstetrics, 55(1), 29–32.CrossRef Ohel, G., & Ruach, M. (1996). Perinatal outcome of idiopathic small for gestational age pregnancies at term: The effect of antenatal diagnosis. International Journal of Gynecology & Obstetrics, 55(1), 29–32.CrossRef
4.
go back to reference Dijxhoorn, M. J., Visser, G. H., Touwen, B. C., & Huisjes, H. J. (1987). Apgar score, meconium and acidaemia at birth in small-for-gestational age infants born at term, and their relation to neonatal neurological morbidity. British Journal of Obstetrics and Gynaecology, 94(9), 873–879.PubMedCrossRef Dijxhoorn, M. J., Visser, G. H., Touwen, B. C., & Huisjes, H. J. (1987). Apgar score, meconium and acidaemia at birth in small-for-gestational age infants born at term, and their relation to neonatal neurological morbidity. British Journal of Obstetrics and Gynaecology, 94(9), 873–879.PubMedCrossRef
5.
go back to reference Doctor, B. A., O’Riordan, M. A., Kirchner, H. L., Shah, D., & Hack, M. (2001). Perinatal correlates and neonatal outcomes of small for gestational age infants born at term gestation. American Journal of Obstetrics and Gynecology, 185(3), 652–659.PubMedCrossRef Doctor, B. A., O’Riordan, M. A., Kirchner, H. L., Shah, D., & Hack, M. (2001). Perinatal correlates and neonatal outcomes of small for gestational age infants born at term gestation. American Journal of Obstetrics and Gynecology, 185(3), 652–659.PubMedCrossRef
6.
go back to reference Villar, J., De, O. M., Kestler, E., Bolanos, F., Cerezo, R., & Bernedes, H. (1990). The differential neonatal morbidity of the intrauterine growth retardation syndrome. American Journal of Obstetrics and Gynecology, 163(1 Pt 1), 151–157.PubMed Villar, J., De, O. M., Kestler, E., Bolanos, F., Cerezo, R., & Bernedes, H. (1990). The differential neonatal morbidity of the intrauterine growth retardation syndrome. American Journal of Obstetrics and Gynecology, 163(1 Pt 1), 151–157.PubMed
7.
go back to reference van den Hove M. M., Willekes C., Roumen F. J., & Scherjon S. A. (2006). Intrauterine growth restriction at term: Induction or spontaneous labour? Disproportionate intrauterine growth intervention trial at term (DIGITAT): A pilot study. European Journal of Obstetrics Gynecology and Reproduction biology, 125(1), 54–58. van den Hove M. M., Willekes C., Roumen F. J., & Scherjon S. A. (2006). Intrauterine growth restriction at term: Induction or spontaneous labour? Disproportionate intrauterine growth intervention trial at term (DIGITAT): A pilot study. European Journal of Obstetrics Gynecology and Reproduction biology, 125(1), 54–58.
8.
go back to reference Boers, K. E., Bijlenga, D., Mol, B. W., LeCessie, S., Birnie, E., van Pampus, M. G., et al. (2007). Disproportionate intrauterine growth intervention trial at term: DIGITAT. BMC Pregnancy Childbirth, 7, 12.PubMedCrossRef Boers, K. E., Bijlenga, D., Mol, B. W., LeCessie, S., Birnie, E., van Pampus, M. G., et al. (2007). Disproportionate intrauterine growth intervention trial at term: DIGITAT. BMC Pregnancy Childbirth, 7, 12.PubMedCrossRef
9.
go back to reference Boers, K. E., Vijgen, S. M., Bijlenga, D., van der Post, J. A., Bekedam, D. J., Kwee, A., et al. (2010). Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT). BMJ, 341, c7087.PubMedCrossRef Boers, K. E., Vijgen, S. M., Bijlenga, D., van der Post, J. A., Bekedam, D. J., Kwee, A., et al. (2010). Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT). BMJ, 341, c7087.PubMedCrossRef
10.
go back to reference Ware, J. E., Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.PubMedCrossRef Ware, J. E., Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.PubMedCrossRef
11.
go back to reference Aaronson, N. K., Muller, M., Cohen, P. D., Essink-Bot, M. L., Fekkes, M., Sanderman, R., et al. (1998). Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. Journal of Clinical Epidemiology, 51(11), 1055–1068.PubMedCrossRef Aaronson, N. K., Muller, M., Cohen, P. D., Essink-Bot, M. L., Fekkes, M., Sanderman, R., et al. (1998). Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. Journal of Clinical Epidemiology, 51(11), 1055–1068.PubMedCrossRef
12.
go back to reference Hoeymans, N., van Lindert, H., & Westert, G. P. (2005). The health status of the Dutch population as assessed by the EQ-6D. Quality of Life Research, 14(3), 655–663.PubMedCrossRef Hoeymans, N., van Lindert, H., & Westert, G. P. (2005). The health status of the Dutch population as assessed by the EQ-6D. Quality of Life Research, 14(3), 655–663.PubMedCrossRef
13.
go back to reference Johnson, J. A., Luo, N., Shaw, J. W., Kind, P., & Coons, S. J. (2005). Valuations of EQ-5D health states: Are the United States and United Kingdom different? Medical Care, 43(3), 221–228.PubMedCrossRef Johnson, J. A., Luo, N., Shaw, J. W., Kind, P., & Coons, S. J. (2005). Valuations of EQ-5D health states: Are the United States and United Kingdom different? Medical Care, 43(3), 221–228.PubMedCrossRef
14.
go back to reference Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370.PubMedCrossRef Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370.PubMedCrossRef
15.
go back to reference Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002). The validity of the hospital anxiety and depression scale. An updated literature review. Journal of Psychosomatic Research, 52(2), 69–77.PubMedCrossRef Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002). The validity of the hospital anxiety and depression scale. An updated literature review. Journal of Psychosomatic Research, 52(2), 69–77.PubMedCrossRef
16.
go back to reference Arrindell, W. A., & Ettema, J. H. M. (2003). Symptom Checklist. Handleiding bij een multidimensionele psychopathologie-indicator. Lisse, The Netherlands: Swets Test Publishers. Arrindell, W. A., & Ettema, J. H. M. (2003). Symptom Checklist. Handleiding bij een multidimensionele psychopathologie-indicator. Lisse, The Netherlands: Swets Test Publishers.
17.
go back to reference Kind, P. (1996). Quality of life and pharmacoeconomics in clinical trials (2nd ed.). Philadelphia, PA: Lippincott-Raven Publishers. Kind, P. (1996). Quality of life and pharmacoeconomics in clinical trials (2nd ed.). Philadelphia, PA: Lippincott-Raven Publishers.
18.
go back to reference Gudex, C., Dolan, P., Kind, P., & Williams, A. (1996). Health state valuations from the general public using the visual analogue scale. Quality of Life Research, 5(6), 521–531.PubMedCrossRef Gudex, C., Dolan, P., Kind, P., & Williams, A. (1996). Health state valuations from the general public using the visual analogue scale. Quality of Life Research, 5(6), 521–531.PubMedCrossRef
19.
go back to reference Spinhoven, P., Ormel, J., Sloekers, P. P., Kempen, G. I., Speckens, A. E., & Van Hemert, A. M. (1997). A validation study of the hospital anxiety and depression scale (HADS) in different groups of Dutch subjects. Psychological Medicine, 27(2), 363–370.PubMedCrossRef Spinhoven, P., Ormel, J., Sloekers, P. P., Kempen, G. I., Speckens, A. E., & Van Hemert, A. M. (1997). A validation study of the hospital anxiety and depression scale (HADS) in different groups of Dutch subjects. Psychological Medicine, 27(2), 363–370.PubMedCrossRef
20.
go back to reference Derogatis, L. R., Lipman, R. S., & Covi, L. (1973). SCL-90: An outpatient psychiatric rating scale–preliminary report. Psychopharmacology Bulletin, 9(1), 13–28.PubMed Derogatis, L. R., Lipman, R. S., & Covi, L. (1973). SCL-90: An outpatient psychiatric rating scale–preliminary report. Psychopharmacology Bulletin, 9(1), 13–28.PubMed
21.
go back to reference Ware, J. E., Kosinski, M., Bjorner, J. B., Turner-Bowker, D. M., Gandek, B., & Maruish, M. E. (2007). User’s manual for the SF-36v2TM health survey. Second Edition. Lincoln, RI: QualityMetric Incorporated. Ware, J. E., Kosinski, M., Bjorner, J. B., Turner-Bowker, D. M., Gandek, B., & Maruish, M. E. (2007). User’s manual for the SF-36v2TM health survey. Second Edition. Lincoln, RI: QualityMetric Incorporated.
22.
go back to reference Bijlenga, D., Koopmans, C. M., Birnie, E., Mol, B. W., van der Post, J. A., Bloemenkamp, K. W., Scheepers, H. C. J., Willekes, C., Kwee, A., Heres, M. H. B., van Beek, E., van Meir, C. A., van Huizen, M. E., van Pampus, M. G., & Bonsel, G. J. (2011). Quality of life after induction of labor versus expectant monitoring in gestational hypertension or preeclampsia at term. Hypertension Pregnancy (in press). Bijlenga, D., Koopmans, C. M., Birnie, E., Mol, B. W., van der Post, J. A., Bloemenkamp, K. W., Scheepers, H. C. J., Willekes, C., Kwee, A., Heres, M. H. B., van Beek, E., van Meir, C. A., van Huizen, M. E., van Pampus, M. G., & Bonsel, G. J. (2011). Quality of life after induction of labor versus expectant monitoring in gestational hypertension or preeclampsia at term. Hypertension Pregnancy (in press).
Metadata
Title
Maternal health-related quality of life after induction of labor or expectant monitoring in pregnancy complicated by intrauterine growth retardation beyond 36 weeks
Authors
Denise Bijlenga
Kim E. Boers
Erwin Birnie
Ben-Willem J. Mol
Sylvia C. M. Vijgen
Joris A. M. Van der Post
Christianne J. De Groot
Robbert J. P. Rijnders
Paula J. Pernet
Frans J. Roumen
Rob H. Stigter
Friso M. C. Delemarre
Henk A. Bremer
Martina Porath
Sicco A. Scherjon
Gouke J. Bonsel
Publication date
01-11-2011
Publisher
Springer Netherlands
Published in
Quality of Life Research / Issue 9/2011
Print ISSN: 0962-9343
Electronic ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-011-9891-x

Other articles of this Issue 9/2011

Quality of Life Research 9/2011 Go to the issue